Video

What Biopharma R&D Steps Are Ripe For Efficiency Gains?

Source: Bioprocess Online

Biological assays, developability assessments, and critical quality attributes are three areas identified by Cullinan Oncology President & CEO Nadim Ahmed and Amgen VP of Research Dr. Robert Stoffel as ripe for efficiency gains. In this segment of the Bioprocess Online Live event Bioprocess R&D: Beginning With The End In Mind, our guest experts address these areas and answer audience questions on the topics.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)